Abstract:Alzheimer's disease is the most common neurodegenerative disease in the elderly. The pathogenesis of the disease is still unkown. β-amyloid (Aβ) has been demonstrated to involve the molecular mechanism of the disease. The aim of the present study is to investigate the toxic effect of the carboxyl-terminal peptide of β-amyloid precursor protein (APPC31) on Neuro2a cells as well as its role in the toxic process in Neuro2a cells induced by Aβ 42 in vitro. The plasmid vector and the APPC31 construct were transiently transfected into Neuro2a cells respectively by lipofectamine 2000. The viability of the cells was measured by the methyl thiazolyl tetrazolium (MTT) assay at 48 h after transfection, and their morphocytology was observed by 4,6-diamino-2-phenyl indole (DAPI) nucleus staining. Afterword different constructs including vector, WTAPP695, APP(D664A), the amino-terminal peptide of β-amyloid precursor protein (APPΔC31) and APPC31 were transiently transfected into Neuro2a cells respectively via the same method. At 24 h after transfection Aβ42 was added into the culture medium of Neuro2a cells with the desired concentration for another 24 h for cell studies. The viability and morphocytology of the cells were measured by using the MTT assay and DAPI nucleus staining, respectively. When incubated in the absence of Aβ42, the viability of cells transfected with vector and APPC31 construct were respective 0.81 ± 0.10 and 0.88 ± 0.12, and accordingly there was no significant difference between the these two groups (t = -0.78, P = 0.48); meanwhile no obvious cell nuclear morphological changes of apoptosis or death occurred. However when incubated in the presence of Aβ42, the viability of cells transfected with vector, WTAPP695, APP(D664A), APP–3C31 and APPC31 constructs were respective 0.82 ± 0.01, 0.78 ± 0.03, 0.55 ± 0.04, 0.81 ± 0.04, 0.78 ± 0.02 and 0.54 ± 0.02. The viability of cells transfected with WTAPP construct and APPC31 construct decreased significantly (F = 47.53, P<0.05) compared with the control group, meanwhile cells displayed condensed nuclear and even nuclear fragmentation. The overexpression of a certain level of APPC31 in Neuro2a cells failed to cause cell death, but this short peptide enhanced cytotoxicity induced by Aβ42 in Neuro2a cells. Thus, these results provided the experimental basis for the further explication of the pathogenesis of Alzheimer's disease.

P3‐309: Overexpression of Hyperphosphorylated Tau Antagonizes Aβ‐potentiated Apoptosis with Preservation of Mitochondrial Elements

Tau Protein Antagonizes Cell Apoptosis Through Akt Pathway

Overexpression Of Tau Proteins Antagonizes Amyloid-Beta-Potentiated Apoptosis Through Mitochondria-Caspase-3 Pathway In N2a Cells

Phosphorylation of Tau Antagonizes Apoptosis by Stabilizing Β-Catenin, a Mechanism Involved in Alzheimer's Neurodegeneration

Tau dephosphorylation potentiates apoptosis by mechanisms involving a failed dephosphorylation/activation of Bcl-2.

Knockdown of phosphotyrosyl phosphatase activator induces apoptosis via mitochondrial pathway and the attenuation by simultaneous tau hyperphosphorylation

Expression of the Hyperphosphorylated Tau Attenuates ER Stress-Induced Apoptosis with Upregulation of Unfolded Protein Response

Effects of Endogenous Β‐amyloid Overproduction on Tau Phosphorylation in Cell Culture

Endogenous Overproduction of Β-Amyloid Induces Tau Hyperphosphorylation and Decreases the Solubility of Tau in N2a Cells

Inhibition of Apoptosis by Hyperphosphorylation of Microtubule-associated Protein Tau at Ser396 Site Induced by Okadaic Acid

Changes In Mitochondrial Dynamics During Amyloid Beta-Induced Pc12 Cell Apoptosis

Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation.

Hyperphosphorylated Tau Stopped Neuronal Apoptosis Induced by Re-Entry Cell Cycle

P2‐142: Toxic Effect of the Carboxyl‐terminal Peptide of Beta‐amyloid Precursor Protein (APPC31) on Neuro2a Cells

Amyloid-β toxicity modulates tau phosphorylation through the PAX6 signalling pathway

Beta-Amyloid-Induced Neurotoxicity Of A Hybrid Septal Cell Line Associated With Increased Tau Phosphorylation And Expression Of Beta-Amyloid Precursor Protein

P2-296: Enhanced Proteolysis of Aβ Peptide Reduces Tau Phosphorylation and Neurofibrillary Tangle Formation in APP/tau Transgenic Mice

[P4–126]: Δ‐secretase–cleaved TAU STIMULATES Aβ PRODUCTION VIA ACTIVATING STAT1‐BACE1 PATHWAY IN ALZHEIMER's DISEASE

Tau Accumulation Impairs Mitophagy Via Increasing Mitochondrial Membrane Potential and Reducing Mitochondrial Parkin.

Hyperphosphorylated Tau Mediates Neuronal Death by Inducing Necroptosis and Inflammation in Alzheimer’s Disease

Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer's disease